Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a new pill help kids fight hepatitis b?

NCT ID NCT02932150

First seen Dec 15, 2025 · Last updated Jun 22, 2026 · Updated 30 times

Summary

This study tests a drug called tenofovir alafenamide (TAF) in 150 children and teens with chronic hepatitis B. Half receive TAF and half receive a placebo for 24 weeks. Researchers are checking how safe the drug is, how the body processes it, and whether it lowers virus levels. The goal is to find a better treatment option for young patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • All India Institute of Medical Sciences

    New Delhi, 110029, India

  • American Research Corporation at Texas Liver Institute

    San Antonio, Texas, 78215, United States

  • Asan Medical Center

    Seoul, 5505, South Korea

  • Chang Gung Medical Foundation, Chang Gung Memorial Hospital, Linkou

    Taoyuan, 33305, Taiwan

  • Chang Gung Medical Foundation, Kaohsiung Chang Gung Memorial Hospital

    Kaohsiung City, 83301, Taiwan

  • Children's Hospital Colorado

    Aurora, Colorado, 80045, United States

  • Children's Hospital of Los Angeles

    Los Angeles, California, 90027, United States

  • Children's Mercy Hospital

    Kansas City, Missouri, 64108, United States

  • Cincinnati Children's Hospital Medical Center

    Cincinnati, Ohio, 45229, United States

  • Cliniques Universitaires Saint-LUC UCL

    Brussels, 1200, Belgium

  • Cook Children's Medical Center

    Fort Worth, Texas, 76104, United States

  • Federal Research Centre of Nutrition, Biotechnology and Food Safety

    Moscow, 115446, Russia

  • Federal State-Financed Institution Pediatric Research and Clinical Center for Infectious Diseases

    Saint Petersburg, 197022, Russia

  • Indiana University School of Medicine

    Indianapolis, Indiana, 46202, United States

  • Institute of Post Graduation Medical Education & Research

    Kolkata, 700020, India

  • Institutul National de Boli Infectioase "Prof.Dr. Matei Bals"

    Bucharest, 21105, Romania

  • Johns Hopkins University

    Baltimore, Maryland, 21287, United States

  • Kaohsiung Medical University Chung-Ho Memorial Hospital

    Kaohsiung City, 807, Taiwan

  • Khalatkar Hospital

    Nagpur, 440009, India

  • Kyungpook National University Hospital

    Daegu, 41944, South Korea

  • LTMMC & LTMG Hospital

    Mumbai, 400022, India

  • Limited Medical Company Hepatolog

    Tolyatti, 445009, Russia

  • M. V Hospital and Research Center

    Lucknow, 226003, India

  • Monroe Carell Jr. Children's Hospital at Vanderbilt

    Nashville, Tennessee, 37232, United States

  • National Cheng Kung University Hospital

    Tainan, 704, Taiwan

  • National Taiwan University Hospital

    Taipei, 100, Taiwan

  • Nationwide Children's Hospital

    Columbus, Ohio, 43205, United States

  • Prince of Wales Hospital

    Shatin, Hong Kong

  • Rady Childrens Hospital

    San Diego, California, 92123, United States

  • Republican Clinical Hospital of Infectious Diseases named after A.F. Agafonov

    Tatarstan, 420110, Russia

  • SIDS Hospital and Research Centre

    Surat, 395002, India

  • Samsung Medical Center

    Seoul, 6351, South Korea

  • Samvedna Hospital

    Varanasi, 221005, India

  • Seattle Children's Hospital

    Seattle, Washington, 98105, United States

  • Seth GS Medical College and KEM Hospital

    Mumbai, 400012, India

  • Spitalul Grigore Alexandrescu-Sectia Pediatrie III

    Bucharest, 11743, Romania

  • Texas Children's Hospital - Main Hospital

    Houston, Texas, 77030, United States

  • The Children's Hospital at Montefiore

    The Bronx, New York, 10467, United States

  • University of California, San Francisco (UCSF)

    San Francisco, California, 94158, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

tenofovir alafenamide (TAF)

What this could lead to

If successful, this could provide a safe and effective treatment option for children with chronic hepatitis B, helping control the virus and reduce liver damage.

What could go wrong

This is an early-phase study with a small number of participants, so results may not apply to all children. The drug may not work better than placebo, and side effects are still being evaluated.

Conditions

The condition(s) this trial relates to.

chronic hepatitis B virus infection hepatitis B virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.